[Federal Register Volume 67, Number 48 (Tuesday, March 12, 2002)]
[Notices]
[Page 11098]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 02-5917]



[[Page 11098]]

-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

National Institute of Standards and Technology


Prospective Grant of Exclusive Patent License

AGENCY: National Institute of Standards and Technology, Commerce.

ACTION: Notice of Prospective Grant of Exclusive Patent License.

-----------------------------------------------------------------------

SUMMARY: This is a notice in accordance with 35 U.S.C. 209(c)(1) and 37 
CFR 404.7(a)(1)(i) that the National Institute of Standards and 
Technology (``NIST''), U.S. Department of Commerce, is contemplating 
the grant of an exclusive license in the United States of America, its 
territories, possessions and commonwealths, to NIST's interest in the 
invention embodied in U.S. Patent Application No. 09/122,583, titled, 
``Designed Protein Pores As Components For Biosensors,'' filed July 24, 
1998; NIST Docket No. 98-016, to the University of Massachusetts, 365 
Plantation Street, Suite, 130, Worcester, MA 01605. The grant of the 
license would be for the field of Biological Applications.

FOR FURTHER INFORMATION CONTACT: J. Terry Lynch, (301) 975-2691, 
National Institute of Standards and Technology, Office of Technology 
Partnerships, 100 Bureau Drive, Stop 2200, Gaithersburg, MD 20899.

SUPPLEMENTARY INFORMATION: The prospective exclusive license will be 
royalty sharing and will comply with the terms and conditions of 35 USC 
209 and 37 CFR 404.7. The prospective exclusive license may be granted 
unless, within thirty days from the date of this published Notice, NIST 
receives written evidence and argument which establish that the grant 
of the license would not be consistent with the requirements of 35 USC 
209 and 37 CFR 404.7. The availability of the invention for licensing 
was published in the Federal Register, Vol. 65, No. 53 (March 17, 
2000).
    U.S. Patent Application No. 09/122,583 is jointly owned by the U.S. 
government, as represented by the Secretary of Commerce, Worcester 
Institute, and the University of Chicago. The present invention relates 
to a mutant staphylococcal alpha hemolysin polypeptide containing a 
heterologous analyte-binding amino acid which assembles into an 
analyte-responsive heteroheptameric pore assembly in the presence of a 
wild type staphylococcal alpha hemolysin polypeptide, digital 
biosensors, and methods of detecting, identifying and quantifying 
analytes.

    Dated: March 5, 2002.
Karen H. Brown,
Deputy Director.
[FR Doc. 02-5917 Filed 3-11-02; 8:45 am]
BILLING CODE 3510-13-P